The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Chimeric Nucleases Stimulate Gene Targeting in Human Cells
Abstract
Correction of gene defects in human somatic cells by targeting as has been used in murine embryonic stem cells (1, 2) has been precluded by the low spontaneous rate of gene targeting (3). However, creation of a DNA double-stranded break (DSB) in the genomic target (DSB-GT) can stimulate homologous recombination by over 1000-fold (4). \n \nWe can rapidly and quantitatively measure gene targeting by correcting a mutation in a green fluorescent protein (GFP) gene that has been stably integrated into the genome (5) (fig. S1). With an optimized GFP gene targeting system, the introduction of a DSB by I–Sce I (Sce) stimulated GT >40,000-fold and the absolute rate of gene targeting reached 3 to 5% (fig. S2). Such a system, however, depends on the prior introduction of a Sce binding site into the target gene and cannot be used for endogenous genes. Chimeric nucleases (CNs) have the potential to create sequence-specific DSBs (6). CNs—fusions between zinc finger binding DNA binding domains and the endonuclease domain of Fok I—can sitespecifically cleave naked DNA in vitro (6), extrachromosomal DNA in Xenopus oocytes (7), and chromosomal DNA in Drosophila (8). CNs work as dimers, and their efficiency depends on the spacing and orientation of the zinc finger binding sites with respect to the length of the amino acid linker between the DNA binding and endonuclease domains (7, 9). \n \nQQR is an artificial zinc finger DNA binding domain that recognizes the sequence 5′-GGGGAAGAA-3′ with nanomolar affinity (10). We modified QQR chimeric nucleases (QQR-CNs) (7, 9) (Fig. 1A) and tested whether they stimulated gene targeting (Fig. 1B). The background rate of gene targeting was 0.71 events per million transfected cells (fig. S1C). QQRL18-CN stimulated gene targeting 17-fold on target QQR6 and 260-fold on target QQR8 (Fig. 1B). QQRL0-CN did not stimulate gene targeting on target QQR8, but it was as efficient as Sce in stimulating gene targeting by over 2000-fold on target QQR6 (Fig. 1B). QQRL18-CN showed some preference for an 8–base pair (bp) spacing between binding sites whereas QQRL0-CN preferred 6-bp spacing. Thus, removing the linker between the zinc spacfinger and the nuclease domains increased the activity and specificity of the fusion protein in mammalian cells. As controls, we showed that the CNs did not stimulate gene targeting if (i) they lacked a nuclear localization signal, (ii) there was a single binding site rather than an inverted repeat binding site in the target, and (iii) the cognate binding site was changed. Thus, homodimers of CNs are potent stimulators of gene targeting in human somatic cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, if the nuclease action mutates unintended targets that are important for cellular physiology, the treated cells may become dysfunctional or even die [61,62,63].”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [62]
In the citing paper
“The fundamental safety concern for using ZFN mediated gene disruption for human therapy is the specificity of gene targeting.”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [62]
Citations
Cites
Altering the Genome by Homologous Recombination
Capecchi, M. R. (1989) · Science · doi:10.1126/science.2660260 · Cited by 2,037
DNA Recognition by Cys2His2 Zinc Finger Proteins
Wolfe, S. A., Nekludova, L., & Pabo, C. O. (2000) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.29.1.183 · Cited by 1,053
Targeted Chromosomal Cleavage and Mutagenesis in Drosophila Using Zinc-Finger Nucleases
Bibikova, M., Golic, M., Golic, K. G., & Carroll, D. (2002) · Genetics · doi:10.1093/genetics/161.3.1169 · Cited by 860
Targetted correction of a mutant HPRT gene in mouse embryonic stem cells
Doetschman, T., Gregg, R., Maeda, N., Hooper, M., Melton, D., Thompson, S., & Smithies, O. (1987) · Nature · doi:10.1038/330576a0 · Cited by 756
Stimulation of Homologous Recombination through Targeted Cleavage by Chimeric Nucleases
Bibikova, M. V., Carroll, D., Segal, D. J., Trautman, J. K., Smith, J., Kim, Y., & Chandrasegaran, S. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.1.289-297.2001 · Cited by 614
Smith, J. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.17.3361 · Cited by 425
Genetic manipulation of genomes with rare-cutting endonucleases
Jasin, M. (1996) · Trends in Genetics · doi:10.1016/0168-9525(96)10019-6 · Cited by 391
Positive genetic selection for gene disruption in mammalian cells by homologous recombination.
Sedivy, J. M., & Sharp, P. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.1.227 · Cited by 119
Specific DNA-RNA Hybrid Binding by Zinc Finger Proteins
Shi, Y., & Berg, J. M. (1995) · Science · doi:10.1126/science.7536342 · Cited by 86
Chimeric Restriction Enzymes: What Is Next?
Chandrasegaran, S., & Smith, J. (1999) · Biological Chemistry · doi:10.1515/bc.1999.103 · Cited by 85
Flagged first, then by citations
Research works printed but not linked: 1
- S. Chandrasegaran, J. Smith, Biol. Chem.380, 841 (1999).
Cited by
Sorted by citations
Items 301–400 of 740
State‐of‐the‐art 2023 on gene therapy for phenylketonuria
Martinez, M., Harding, C. O., Schwank, G., & Thöny, B. (2023) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12651 · Cited by 40
Shen, J.-Y., Zhao, Q., & He, Q. (2023) · ACS Synthetic Biology · doi:10.1021/acssynbio.3c00099 · Cited by 39
Semaan, M., Ivanusic, D., & Denner, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122059 · Cited by 39
Adding Fingers to an Engineered Zinc Finger Nuclease Can Reduce Activity
Shimizu, Y., Şöllü, C., Meckler, J. F., Adriaenssens, A. E., Zykovich, A., Cathomen, T., & Segal, D. J. (2011) · Biochemistry · doi:10.1021/bi200393g · Cited by 38
Common therapeutic advances for Duchenne muscular dystrophy (DMD)
Salmaninejad, A., Abarghan, Y. J., Qomi, S. B., Bayat, H., Yousefi, M., Azhdari, S., Talebi, S., & Mojarrad, M. (2020) · International Journal of Neuroscience · doi:10.1080/00207454.2020.1740218 · Cited by 41
Targeted mutagenesis in the progeny of maize transgenic plants
Yang, M., Djukanovic, V., Stagg, J., Lenderts, B., Bidney, D. L., Falco, S. C., & Lyznik, L. A. (2009) · Plant Molecular Biology · doi:10.1007/s11103-009-9499-5 · Cited by 38
Receptor-mediated delivery of engineered nucleases for genome modification
Chen, Z., Jaafar, L., Agyekum, D. G., Xiao, H., Wade, M. F., Kumaran, R., Spector, D. L., Bao, G., Porteus, M. H., Dynan, W. S., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt710 · Cited by 38
Self-citationGabsalilow, L., Schierling, B., Friedhoff, P., Pingoud, A. M., & Wende, W. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt080 · Cited by 38
Shah, R., Cholewa-Waclaw, J., Davies, F. C. J., Paton, K. M., Chaligné, R., Heard, É., Abbott, C. M., & Bird, A. P. (2016) · Wellcome Open Research · doi:10.12688/wellcomeopenres.10011.1 · Cited by 38
Triplex-Stimulated Intermolecular Recombination at a Single-Copy Genomic Target
Knauert, M. P., Kalish, J. M., Hegan, D. C., & Glazer, P. M. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.03.020 · Cited by 38
Olsen, P. A., Solhaug, A., Booth, J. A., Gelazauskaite, M., & Krauss, S. J. K. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.11.011 · Cited by 37
Quantification of Zinc Finger Nuclease-Associated Toxicity
Cornu, T. I., & Cathomen, T. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-753-2_14 · Cited by 40
Gene Therapy for Autosomal Dominant Disorders of Keratin
Lewin, A. S., Glazer, P. M., & Milstone, L. M. (2005) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1111/j.1087-0024.2005.10207.x · Cited by 40
van Nierop, G. P., de Vries, A. A. F., Holkers, M., Vrijsen, K. R., & Gonçalves, M. A. F. V. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp643 · Cited by 37
Mouse genetics: Catalogue and scissors
Sung, Y. H., Baek, I., Seong, J. K., Kim, J., & Lee, H. (2012) · BMB Reports · doi:10.5483/bmbrep.2012.45.12.242 · Cited by 36
The expanding footprint of CRISPR/Cas9 in the plant sciences
Schaeffer, S. M., & Nakata, P. A. (2016) · Plant Cell Reports · doi:10.1007/s00299-016-1987-x · Cited by 37
CRISPR/Cas-Dependent and Nuclease-Free In Vivo Therapeutic Gene Editing
Dasgupta, I., Flotte, T. R., & Keeler, A. M. (2021) · Human Gene Therapy · doi:10.1089/hum.2021.013 · Cited by 38
Detection of genome edits in plants—from editing to seed
Shillito, R. D., Whitt, S. R., Ross, M., Ghavami, F., Vleesschauwer, D. D., D’Halluin, K., Hoecke, A. V., & Meulewaeter, F. (2021) · In Vitro Cellular & Developmental Biology - Plant · doi:10.1007/s11627-021-10214-z · Cited by 36
Genome modification in human embryonic stem cells
Tenzen, T., Zembowicz, F., & Cowan, C. A. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21948 · Cited by 39
Zinc finger nuclease technology: Advances and obstacles in modelling and treating genetic disorders
Jabalameli, H. R., Zahednasab, H., Moghadam, A. K., & Jabalameli, M. R. (2014) · Gene · doi:10.1016/j.gene.2014.12.044 · Cited by 39
Design and Testing of Zinc Finger Nucleases for Use in Mammalian Cells
Porteus, M. H. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-232-8_4 · Cited by 36
Self-citationLin, W., Hu, S., Li, K., Shi, Y., Pan, C., Xu, Z., Li, D., Wang, H. H., Li, B., & Chen, H. (2023) · Small · doi:10.1002/smll.202307595 · Cited by 37
TALEN-Mediated Modification of the Bovine Genome for Large-Scale Production of Human Serum Albumin
Moghaddassi, S., Eyestone, W., & Bishop, C. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089631 · Cited by 35
Programmable Site-Specific Nucleases for Targeted Genome Engineering in Higher Eukaryotes
Govindan, G., & Ramalingam, S. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25367 · Cited by 38
Statistical analysis of structural determinants for protein–DNA‐binding specificity
Corona, R. I., & Guo, J. (2016) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.25061 · Cited by 35
Fan, L., Frye, C. C., & Racher, A. J. (2013) · Pharmaceutical Bioprocessing · doi:10.4155/pbp.13.56 · Cited by 35
Nanomedicine: Tiny Particles and Machines Give Huge Gains
Tong, S., Fine, E. J., Lin, Y., Cradick, T. J., & Bao, G. (2013) · Annals of Biomedical Engineering · doi:10.1007/s10439-013-0952-x · Cited by 34
Recent developments and clinical studies utilizing engineered zinc finger nuclease technology
Jo, Y.-I., Kim, S., & Ramakrishna, S. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1956-5 · Cited by 37
Targeted mutagenesis in zebrafish
Woods, I. G., & Schier, A. F. (2008) · Nature Biotechnology · doi:10.1038/nbt0608-650 · Cited by 34
Slavny, P., Hegde, M., Doerner, A., Parthiban, K., McCafferty, J., Zielonka, S., & Hoet, R. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1469329 · Cited by 33
Update on Progress and Hurdles in Novel Genetic Therapies for Hemophilia
High, K. A. (2007) · Hematology · doi:10.1182/asheducation-2007.1.466 · Cited by 32
Huang, N., Huang, Z., Gao, M., Luo, Z., Zhou, F., Liu, L., Xiao, Q., Wang, X., & Feng, W. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0732-4 · Cited by 32
Diverse Approaches to Gene Therapy of Sickle Cell Disease
White, S. L., Hart, K. L., & Kohn, D. B. (2022) · Annual Review of Medicine · doi:10.1146/annurev-med-042921-021707 · Cited by 33
'Magic' scissors for genome surgery
Kandavelou, K., Mani, M., Sundar, D., & Chandrasegaran, S. (2005) · Nature Biotechnology · doi:10.1038/nbt0605-686 · Cited by 33
Creation of a type IIS restriction endonuclease with a long recognition sequence
Lippow, S. M., Aha, P. M., Parker, M. H., Blake, W. J., Baynes, B. M., & Lipovšek, D. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp182 · Cited by 33
Lombardo, A., Genovese, P., Beausejour, C. M., Colleoni, S., Lee, Y.-L., Kim, K. A., Ando, D. G., Urnov, F. D., Galli, C., Gregory, P. D., et al. (2008) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2007.10.064 · Cited by 32
Adeno-associated virus inverted terminal repeats stimulate gene editing
Hirsch, M. L. (2015) · Gene Therapy · doi:10.1038/gt.2014.109 · Cited by 32
Efficient creation of an APOE knockout rabbit
Ji, D., Zhao, G., Songstad, A. E., Cui, X., & Weinstein, E. J. (2014) · Transgenic Research · doi:10.1007/s11248-014-9834-8 · Cited by 34
Gartzke, D., Delzer, J., Laplanche, L., Uchida, Y., Hoshi, Y., Tachikawa, M., Terasaki, T., Sydor, J. R., & Fricker, G. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1599-5 · Cited by 32
Homologous recombination in human cells using artificial restriction DNA cutter
Katada, H., Chen, H. J., Shigi, N., & Komiyama, M. (2009) · Chemical Communications · doi:10.1039/b912030k · Cited by 32
Human induced pluripotent stem cells for monogenic disease modelling and therapy
Spitalieri, P., Talarico, V. R., Murdocca, M., Novelli, G., & Sangiuolo, F. C. (2016) · World Journal of Stem Cells · doi:10.4252/wjsc.v8.i4.118 · Cited by 34
Luo, Z., Gao, M., Huang, N., Wang, X., Yang, Z., Yang, H., Huang, Z., & Feng, W. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1229-5 · Cited by 33
Genome Editing of the Germline: Broadening the Discussion
Porteus, M. H., & Dann, C. T. (2015) · Molecular Therapy · doi:10.1038/mt.2015.83 · Cited by 32
Self-citationEnrichment strategies to enhance genome editing
Mikkelsen, N. S., & Bak, R. O. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00943-1 · Cited by 32
Olsen, P. A., Gelazauskaite, M., Randøl, M., & Krauss, S. J. K. (2010) · BMC Molecular Biology · doi:10.1186/1471-2199-11-35 · Cited by 32
Targeting the absence: Homozygous DNA deletions as immutable signposts for cancer therapy
Varshavsky, A. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706546104 · Cited by 31
The I-TevI Nuclease and Linker Domains Contribute to the Specificity of Monomeric TALENs
Kleinstiver, B. P., Wang, L., Wolfs, J. M., Kolaczyk, T., McDowell, B., Wang, X., Schild‐Poulter, C., Bogdanove, A. J., & Edgell, D. R. (2014) · G3 Genes Genomes Genetics · doi:10.1534/g3.114.011445 · Cited by 31
Induced Pluripotent Stem Cells in Dermatology: Potentials, Advances, and LimitationsPreprint
Bilousova, G., & Roop, D. R. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a015164 · Cited by 31
Efficient mutagenesis of the rhodopsin gene in rod photoreceptor neurons in mice
Chan, F., Hauswirth, W. W., Wensel, T. G., & Wilson, J. H. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr196 · Cited by 32
The Rise of CRISPR/Cas for Genome Editing in Stem Cells
Shui, B., Hernández-Matías, L., Guo, Y., & Peng, Y. (2016) · Stem Cells International · doi:10.1155/2016/8140168 · Cited by 33
CRISPR-Cas9 System as a Versatile Tool for Genome Engineering in Human Cells
Wang, X., Huang, X., Fang, X., Zhang, Y., & Wang, W. (2016) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2016.95 · Cited by 30
Sharma, R., Dever, D. P., Lee, C. M., Azizi, A., Pan, Y., Camarena, J., Köhnke, T., Bao, G., Porteus, M. H., & Majeti, R. (2021) · Nature Communications · doi:10.1038/s41467-020-20792-y · Cited by 30
Self-citationUsing defined finger–finger interfaces as units of assembly for constructing zinc-finger nucleases
Zhu, C., Gupta, A., Hall, V. L., Rayla, A. L., Christensen, R. G., Dake, B. T., Lakshmanan, A., Kuperwasser, C., Stormo, G. D., & Wolfe, S. A. (2013) · Nucleic Acids Research · doi:10.1093/nar/gks1357 · Cited by 31
Directed evolution of homing endonuclease I-SceI with altered sequence specificity
Chen, Z., Wen, F., Sun, N., & Zhao, H. (2009) · Protein Engineering Design and Selection · doi:10.1093/protein/gzp001 · Cited by 29
Targeted Mutagenesis for Functional Analysis of Gene Duplication in Legumes
Curtin, S. J., Anderson, J., Starker, C. G., Baltes, N. J., Mani, D., Voytas, D. F., & Stupar, R. M. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-613-9_3 · Cited by 29
Introduction to Cancer Stem Cells: Past, Present, and Future
Bakhshinyan, D., Adile, A., Qazi, M. A., Singh, M., Kameda-Smith, M. M., Yelle, N., Chokshi, C., Venugopal, C., & Singh, S. K. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7401-6_1 · Cited by 30
Prìeto, J., Redondo, P. N., Padró, D., Arnould, S., Epinat, J.-C., Pâques, F., Blanco, F. J., & Montoya, G. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm183 · Cited by 29
Creation of herbicide-tolerant crops by gene targeting
Endo, M., & Toki, S. (2013) · Journal of Pesticide Science · doi:10.1584/jpestics.d12-073 · Cited by 29
Modeling and correction of structural variations in patient-derived iPSCs using CRISPR/Cas9
Park, C., Sung, J. J., Choi, S.-H., Lee, D. R., Park, I., & Kim, D. (2016) · Nature Protocols · doi:10.1038/nprot.2016.129 · Cited by 28
CRISPR-based therapeutic genome editing for inherited blood disorders
Levesque, S., & Bauer, D. E. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01236-y · Cited by 31
Katz, S. S., Gimble, F. S., & Storici, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088840 · Cited by 27
Genome engineering: the next genomic revolution
Gersbach, C. A. (2014) · Nature Methods · doi:10.1038/nmeth.3113 · Cited by 27
High-throughput genetic screens using CRISPR–Cas9 system
Kweon, J., & Kim, Y. (2018) · Archives of Pharmacal Research · doi:10.1007/s12272-018-1029-z · Cited by 27
Meng, X., Thibodeau-Beganny, S., Jiang, T., Joung, J. K., & Wolfe, S. A. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm385 · Cited by 26
Suñé-Pou, M., Limeres, M. J., Moreno‐Castro, C., Hernández-Munaín, C., Suñé-Negre, J. M., Cuestas, M. L., & Suñé, C. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00731 · Cited by 27
HMEJ-mediated efficient site-specific gene integration in chicken cells
Xie, L., Sun, J., Mo, L., Xu, T., Shahzad, Q., Chen, D., Yang, W., Liao, Y., & Lu, Y. (2019) · Journal of Biological Engineering · doi:10.1186/s13036-019-0217-9 · Cited by 26
Liu, X., Liu, M., XUE, Z., Pan, Q., WU, L., Long, Z., Xia, K., LIANG, D., & Jia Hui, X. I. A. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02355.x · Cited by 26
Targeted genome editing in pluripotent stem cells using zinc-finger nucleases
Bobis‐Wozowicz, S., Osiak, A., Rahman, S. H., & Cathomen, T. (2010) · Methods · doi:10.1016/j.ymeth.2010.12.019 · Cited by 25
Towards Artificial Metallonucleases for Gene Therapy: Recent Advances and New Perspectives
Gyurcsik, B., & Czene, A. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.139 · Cited by 24
Bertolini, L. R., BERTOLINI, M., ANDERSON, G., Maga, E. A., Madden, K. R., & MURRAY, J. (2006) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2006.10.003 · Cited by 24
Therapeutic editing of hepatocyte genome in vivo
de Galarreta, M. R., & Lujambio, A. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.012 · Cited by 25
Assessing Public Opinion on CRISPR-Cas9: Combining Crowdsourcing and Deep Learning
Müller, M., Schneider, M., Salathé, M., & Vayena, E. (2020) · Journal of Medical Internet Research · doi:10.2196/17830 · Cited by 26
Shirk, B. D., Shirk, P. D., Furlong, R. B., Scully, E. D., Wu, K., & Siegfried, B. D. (2022) · SSRN Electronic Journal · doi:10.1016/j.jinsphys.2022.104471 · Cited by 24
Yang, X., Bui, T. A., Mei, H., Aksoy, Y. A., Deng, F., Hutvágner, G., & Deng, W. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202402630 · Cited by 28
Wilson, K. A., Chateau, M., & Porteus, M. H. (2013) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2013.12 · Cited by 23
Self-citationKhan, A. A., El-Sayed, A., Akbar, A., Mangravita-Novo, A., Bibi, S., Naveed, Z. A., Norman, D. J., & Ali, G. S. (2017) · Plant Methods · doi:10.1186/s13007-017-0236-9 · Cited by 23
Oligo/Polynucleotide-Based Gene Modification: Strategies and Therapeutic Potential
Sargent, R. G., Kim, S., & Gruenert, D. C. (2011) · Oligonucleotides · doi:10.1089/oli.2010.0273 · Cited by 23
Application of CRISPR-Cas9 gene editing for congenital heart disease
Seok, H., Deng, R., Cowan, D. B., & Wang, D. (2021) · Korean Journal of Pediatrics · doi:10.3345/cep.2020.02096 · Cited by 23
Generation of genetically modified mice using CRISPR/Cas9 and haploid embryonic stem cell systems.
Jin, L., & Li, J. (2016) · Europe PMC (PubMed Central) · doi:10.13918/j.issn.2095-8137.2016.4.205 · Cited by 22
Chien, J. C.-Y., Tabet, E. I., Pinkham, K., da Hora, C. C., Chang, J. C.-Y., Lin, S., Badr, C. E., & Lai, C. P. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa669 · Cited by 21
Development of nuclease-mediated site-specific genome modification
Wirt, S. E., & Porteus, M. H. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.08.005 · Cited by 21
Self-citationYou can't keep a bad idea down: Dark history, death, and potential rebirth of eugenics
Liscum, M., & Garcia, M. L. (2021) · The Anatomical Record · doi:10.1002/ar.24849 · Cited by 26
Lu, Y., Mbakam, C. H., Song, B., Bendavid, E., & Tremblay, J. P. (2022) · Frontiers in Genome Editing · doi:10.3389/fgeed.2022.892769 · Cited by 22
Using Homologous Recombination to Manipulate the Genome of Human Somatic Cells
Porteus, M. H. (2007) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2007.10648100 · Cited by 21
Self-citationAptamer-guided gene targeting in yeast and human cells
Ruff, P., Koh, K. D., Keskin, H., Pai, R. B., & Storici, F. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku101 · Cited by 21
Genome Editing in Mouse Spermatogonial Stem/Progenitor Cells Using Engineered Nucleases
Fanslow, D. A., Wirt, S. E., Barker, J. C., Connelly, J. P., Porteus, M. H., & Dann, C. T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112652 · Cited by 23
Self-citationGenome Editing with CRISPR‐Cas: An Overview
Robb, G. B. (2019) · Current Protocols Essential Laboratory Techniques · doi:10.1002/cpet.36 · Cited by 24
A Crisper Look at Genome Editing: RNA-guided Genome Modification
Damian, M., & Porteus, M. H. (2013) · Molecular Therapy · doi:10.1038/mt.2013.46 · Cited by 22
Self-citationCRISPR/Cas and Argonaute-powered lateral flow assay for pathogens detection
Li, Y., Zhao, L., Ma, L., Bai, Y., & Feng, F. (2024) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2024.2416473 · Cited by 20
Advancements in genome editing tools for genetic studies and crop improvement
Ahmadikhah, A., Zarabizadeh, H., Nayeri, S., & Abbasi, M. S. (2025) · Frontiers in Plant Science · doi:10.3389/fpls.2024.1370675 · Cited by 21
Genome editing in pluripotent stem cells: research and therapeutic applications
Deleidi, M., & Yu, C. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.02.113 · Cited by 20
Protocol of Phytophthora capsici Transformation Using the CRISPR-Cas9 System
Wang, Z., Tyler, B. M., & Liu, X. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8724-5_17 · Cited by 20
Engineering T Cells Using CRISPR/Cas9 for Cancer Therapy
Zhang, X., Cheng, C., Sun, W. C., & Wang, H. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0290-4_23 · Cited by 20
Efficient correction of a deleterious point mutation in primary horse fibroblasts with CRISPR-Cas9
Pinzón-Arteaga, C. A., Snyder, M. D., Lazzarotto, C. R., Moreno, N. F., Juras, R., Raudsepp, T., Golding, M. C., Varner, D. D., & Long, C. R. (2020) · Scientific Reports · doi:10.1038/s41598-020-62723-3 · Cited by 21
Generation and Functional Analysis of Zinc Finger Nucleases
Cathomen, T., Segal, D. J., Brondani, V., & Müller-Lerch, F. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-248-3_17 · Cited by 20
Genome Editing in Human Pluripotent Stem Cells Using Site-Specific Nucleases
Chiba, K., & Hockemeyer, D. F. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1862-1_15 · Cited by 21
Kalamakis, G., & Platt, R. J. (2023) · Neuron · doi:10.1016/j.neuron.2023.04.021 · Cited by 20
Viral Hybrid Vectors for Somatic Integration - Are They the Better Solution?
Müther, N., Noske, N., & Ehrhardt, A. (2009) · Viruses · doi:10.3390/v1031295 · Cited by 18
Efficient CRISPR/Cas9‐Based Genome Engineering in Human Pluripotent Stem Cells
Kime, C., Mandegar, M. A., Srivastava, D., Yamanaka, S., Conklin, B. R., & Rand, T. (2016) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg2104s88 · Cited by 20
Mimicking Retinal Development and Disease With Human Pluripotent Stem Cells
Sinha, D., Phillips, J., Phillips, M. J., & Gamm, D. M. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-18160 · Cited by 21
Metadata
- Authors
- Porteus, M. H., & Baltimore, D.
- Affiliations
- California Institute of Technology (US)
- Corresponding author
- Porteus, Matthew H.
- Baltimore, David
- Venue
- Science
- Published
- 2003-05-02
- Volume
- 300
- Issue
- 5620
- Pages
- 763-763
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2051395442
- Cited by
- 741
- References
- 10
- Citations by year
- 2026: 8 · 2025: 18 · 2024: 25 · 2023: 16 · 2022: 26 · 2021: 30 · 2020: 34 · 2019: 33 · 2018: 27 · 2017: 28 · 2016: 52 · 2015: 45 · 2014: 69 · 2013: 41 · 2012: 51
- FWCI
- 9.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM039458, R01 GM39458)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- gene targeting, homologous recombination, zinc finger DNA-binding domain, DNA double-strand breaks, linker length, somatic cell therapy, gene therapy vectors, somatic cell hybrids, somatic cell nuclear transfer
- MeSH terms
- Cell Line, DNA, Humans, Luminescent Proteins, Mutation, Recombinant Fusion Proteins, Recombination, Genetic, Transfection, Deoxyribonucleases, Type II Site-Specific, Zinc Fingers, Gene Targeting, Dimerization, Nuclear Localization Signals, Saccharomyces cerevisiae Proteins, Green Fluorescent Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review